Petwealth Launches Functional Health Testing Platform with Kennel Connection and Pawp Partnerships
Petwealth, a Miami-based diagnostics platform, emerged from stealth with $1.7M in funding and exclusive partnerships with Kennel Connection and Pawp. The startup offers at-home PCR testing screening 100+ health markers for dogs and cats, positioning itself in the growing functional pet health market.
Petwealth launched with a flagship product, The Petwealth Pack, priced at $399 for a comprehensive at-home testing kit that screens 100+ health markers across fecal, oral, and respiratory samples. The company also offers individual panels at $175 each. Results arrive within 24 to 48 hours paired with AI-generated health insights.
What Happened
Petwealth launched with a flagship product, The Petwealth Pack, priced at $399 for a comprehensive at-home testing kit that screens 100+ health markers across fecal, oral, and respiratory samples. The company also offers individual panels at $175 each. Results arrive within 24 to 48 hours paired with AI-generated health insights.
The startup's timing aligns with two critical industry partnerships. An exclusive diagnostic partnership with Kennel Connection—a management platform operating across 5,500+ U.S. pet care locations (daycares, boarding facilities, groomers, pet hotels)—embeds Petwealth's testing into daily facility operations. A parallel integration with Pawp, a 24/7 pet telehealth service, connects diagnostic results directly to licensed veterinarians for immediate interpretation.
The company was founded by Angelo Palivos in 2025, following his dog Mochi's death. Petwealth's positioning mirrors the "quantified self" trend now moving into pet health: Function Health for people, Petwealth for pets.
Why It Matters
1. Preventive care reshaping market expectations. Pet owners increasingly view diagnostics not as reactive tools but as baseline wellness infrastructure. The pet health market is projected to reach $510.9 billion by 2035, with diagnostic devices emerging as one of the fastest-growing subsegments. Petwealth's approach targets owners willing to spend $399 upfront on functional health screening—a shift from crisis-driven veterinary visits to ongoing health optimization.
2. Integration is the differentiator. The pet tech ecosystem remains fragmented. Petwealth collapses multiple steps by embedding diagnostics into existing platforms (Kennel Connection for B2B operations) and tying results directly to veterinary guidance (Pawp). This positions the company as a workflow layer rather than a standalone test kit manufacturer.
3. B2B facility operators are hungry for health differentiation. Kennel Connection's 5,500+ client locations operate on thin margins and compete heavily on service quality. Adding clinical-grade PCR screening to boarding or daycare is a value-add that reduces liability, improves transparency, and appeals to health-conscious pet owners.
4. Telehealth is solving the diagnostics interpretation problem. Pet owners purchasing at-home tests often lack veterinary training to act on results. Pawp's 24/7 availability removes the friction of scheduling vet appointments post-diagnosis, converting diagnostic data into actionable guidance in minutes rather than days.
5. The competitive landscape is heating up without clear market leaders. Established diagnostics players like IDEXX hold roughly half the veterinary diagnostics market. But at-home pet testing remains fragmented among players like Vetevo, MySimplePetLab, and Basepaws. Petwealth's PCR-based functional health screening is different from these players, but it's also an unproven category.
What to Watch
Funding velocity. Petwealth is currently raising a pre-seed round on top of $1.7 million already deployed. Watch for Series A timing and investor focus.
Adoption within Kennel Connection. Monitor how many of Kennel Connection's 5,500+ locations actually integrate Petwealth into their operations, and at what rate.
Competitive responses. IDEXX and Mars Petcare's Antech Diagnostics may expand at-home offerings. Petwealth's partnerships may prove more defensible than its technology.
Pricing power and reorder rates. At $399 for a full pack, the company is betting on recurring purchases. Watch whether customers view this as a one-time baseline or an annual wellness ritual.
Other News
More stories shaping the pet industry this week. From funding rounds and product launches to regulatory shifts and retail strategy, stay ahead of what's driving the market.
Woof Extends HonestChew Into Consumables With Real-Beef-Coated SKU
Woof launched HonestChew Meaty, a real-beef-coated plant-core chew, marking its push from enrichment toys into the consumables category.
Dutch Recruits Tara Lipinski as "Chief Pet Officer" to Push Access Narrative as Vet Costs Bite
Dutch named Olympic champion Tara Lipinski its Chief Pet Officer, tying the move to a Pet Care Gap Report claiming 75 million Americans skip vet care.
Chewy's $600M Guidance Raise Is Really About the Vet Clinics
Chewy raised fiscal 2026 net sales guidance to $13.6–$13.8 billion on April 9, roughly $600 million above consensus, and told investors Chewy Vet Care is now the fastest-growing segment by net sales per active customer. Management also assumed zero price inflation across the 2026 plan, a revealed-preference signal that Chewy will absorb supplier cost pressure rather than pass it through — with direct implications for every brand selling on the platform.